THE ODSMT BUY DIARIES

It's a drug created by Hoffmann-La Roche which acts like a potent and selective unfavorable allosteric modulator for group II from the metabotropic glutamate receptors (mGluR2/3), remaining equipotent at mGluR2 and mGluR3 but with no action at other mGluR subtypes.Critical pores and skin reactions: VOQUEZNA may cause rare, but serious skin reaction